Shanghai Rendu Financials
| 688193 Stock | 37.18 0.45 1.20% |
Shanghai |
Understanding current and past Shanghai Rendu Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Shanghai Rendu's financial statements are interrelated, with each one affecting the others. For example, an increase in Shanghai Rendu's assets may result in an increase in income on the income statement.
Please note, the presentation of Shanghai Rendu's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Shanghai Rendu's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Shanghai Rendu's management manipulating its earnings.
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Instrument | China Stock View All |
| Exchange | Shanghai Stock Exchange |
| ISIN | CNE1000059K5 |
| Business Address | Zhangjiang High Tech |
| Sector | Biotechnology |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.rdbio.com |
| Phone | 86 21 5072 0200 |
You should never invest in Shanghai Rendu without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Shanghai Stock, because this is throwing your money away. Analyzing the key information contained in Shanghai Rendu's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Shanghai Rendu Key Financial Ratios
Shanghai Rendu's financial ratios allow both analysts and investors to convert raw data from Shanghai Rendu's financial statements into concise, actionable information that can be used to evaluate the performance of Shanghai Rendu over time and compare it to other companies across industries.| Return On Equity | -0.0078 | ||||
| Return On Asset | -0.0062 | ||||
| Beta | 0.21 |
Shanghai Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Shanghai Rendu's current stock value. Our valuation model uses many indicators to compare Shanghai Rendu value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Shanghai Rendu competition to find correlations between indicators driving Shanghai Rendu's intrinsic value. More Info.Shanghai Rendu Biotechnology is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Shanghai Rendu by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Shanghai Rendu's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Shanghai Rendu Biote Systematic Risk
Shanghai Rendu's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Shanghai Rendu volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on Shanghai Rendu Biote correlated with the market. If Beta is less than 0 Shanghai Rendu generally moves in the opposite direction as compared to the market. If Shanghai Rendu Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Shanghai Rendu Biote is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Shanghai Rendu is generally in the same direction as the market. If Beta > 1 Shanghai Rendu moves generally in the same direction as, but more than the movement of the benchmark.
Shanghai Rendu March 29, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Shanghai Rendu help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Shanghai Rendu Biotechnology. We use our internally-developed statistical techniques to arrive at the intrinsic value of Shanghai Rendu Biotechnology based on widely used predictive technical indicators. In general, we focus on analyzing Shanghai Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Shanghai Rendu's daily price indicators and compare them against related drivers.
| Downside Deviation | 2.21 | |||
| Information Ratio | 0.0466 | |||
| Maximum Drawdown | 9.52 | |||
| Value At Risk | (3.13) | |||
| Potential Upside | 4.73 |
Complementary Tools for Shanghai Stock analysis
When running Shanghai Rendu's price analysis, check to measure Shanghai Rendu's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Shanghai Rendu is operating at the current time. Most of Shanghai Rendu's value examination focuses on studying past and present price action to predict the probability of Shanghai Rendu's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Shanghai Rendu's price. Additionally, you may evaluate how the addition of Shanghai Rendu to your portfolios can decrease your overall portfolio volatility.
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |